ERCC4 and sarcoma: Incidentally, the ISKS reported an excess of pathogenic variants in ERCC2. The observation of ERCC2 and ERCC4 predicted pathogenic mutations in our study and the ISKS, coupled with the early age-of-onset in our two patients, suggests a potential role for the nucleotide excision repair (NER) pathway in sarcoma predisposition.